Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 5
Submit an article Journal homepage
59
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma

Murray S. Webb Inex Pharmaceuticals Corporation 100-8900 Glenlyon Parkway, Burnaby, BC, Canada
,
David L. Saltman Inex Pharmaceuticals Corporation 100-8900 Glenlyon Parkway, Burnaby, BC, Canada
,
Joseph M. Connors British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
&
James H. Goldie British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
Pages 975-982 | Published online: 01 Jul 2009

  • Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. and Harousseau, J.L. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine 333, 1540 - 1545
  • Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughlin, P., Fridrik, M., Tucker, S., Jagannath, S., Hagemeister, F.B., Redman, J.R. and Swan, F. (1988) "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)", Blood 71, 117 - 122
  • Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. and Cabanillas, F. (1994) "ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study", Journal of Clinical Oncology 12, 1169 - 1176
  • Wilson, W.H., Bryant, G., Bates, S., Fojo, A., Wittes, R.E., Steinberg, S.M., Kohler, D.R., Jaffe, E.S., Herdt, J., Cheson, B.C. and Chabner, B.A. (1993) "EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma", Journal of Clinical Oncology 11, 1573 - 1582
  • Hoskins, P.J., Le, N., Gascoyne, R.D., Klasa, R., Shenkier, T., O'Reilly, S. and Connors, J.M. (1997) "Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variable defining outcome after relapse", Annals of Oncology 18, 1125 - 1132
  • Meehan, K.R., Pritchard, R.S., Leichter, J.W., Littenberg, B. and Welch, H.G. (1995) "Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature", American Journal of Hematology 50, 116 - 123
  • Barth, D., Brandwein, J., Quirt, I. and Imrie, K. (1998) "Outcome of chemotherapy for relapsed intermediate grade non-Hodgkin's lymphoma (IG-NHL) in patients over the age of sixty years (abstract)", Blood 92, 234b
  • Dincol, D., Icli, F., Karaoguz, H., et al., (1995) "Mesna/Ifosfamide, Mitoxantrone, Etoposide, Bleomycin, Vincristine, Prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma", Acta Oncologica 34, 937 - 940
  • Garay, G., Dupont, J., Dragosky, M., et al., (1997) "Combination salvage chemotherapy with MIZE (Ifosfamide-Mesna, Idarubicin and Etoposide) for relapsing or refractory lymphoma", Leukemia and Lymphoma 26, 595 - 602
  • Romaguera, J.E., Rodriguez, M.A., Hagemeister, F.B., McLaughlin, P., Rodriguez, J., Preti, A.H., Younes, A., Sarris, A.H. and Cabanillas, F. (1999) "Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or resistant or refractory non-Hodgkin's lymphoma (NHL) failing a doxorubicin-containing regimen and a cytarabine/cisplatin-containing regimen", Blood 94 (Suppl. 1), 267b
  • Alizadeh, A.A., Eiren, M.B., Davis, R.E., et al., (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature 403, 503 - 512
  • Case, Jr, D.C., Gerber, M.C., Gams, R.A., Crawford, J., Votaw, M.L., Higano, C.S., Pruitt, B.T. and Gould, J. (1992) "Phase II study of intravenous idarubicin in unfavourable non-Hodgkin's lymphoma", Leukemia and Lymphoma 10, 73 - 79
  • Niitsu, N. and Umeda, M. (1997) "Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma", American Journal of Clinical Oncology 20, 311 - 314
  • Haim, N., Ben-Shahar, M. and Epelbaum, R. (1995) "Prolonged daily administration of oral etoposide in lymphoma following prior therapy with Adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide", Cancer Chemotherapy and Pharmacology 36, 352 - 355
  • Hainsworth, J.D., Johnson, D.H. and Greco, F.A. (1992) "Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma", Seminars in Oncology 19, 13 - 18
  • Younes, A., Ayoub, J.P., Sarris, A., Hagemeister, F., North, L., Pate, O., McLaughlin, P., Rodriguez, M.A., Romaguera, J., Kurzrock, R., Preti, A., Bacher, C., Smith, T. and Cabanillas, F. (1997) "Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial", British Journal of Haematology 96, 328 - 332
  • Younes, A., Sarris, A., Melnyk, A., et al., (1995) "Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma", Journal of Clinical Oncology 13, 583 - 587
  • Younes, A., Ayoub, J.P., Hagemeister, F.B., McLaughlin, P., Sarris, A., Rodriquez, M.A., Swan, F., Romaguera, J.E., Martin, J. and Cabanillas, F. (1996) "No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-infusion schedule", Journal of Clinical Oncology 14, 543 - 548
  • Wilson, W.H., Chabner, B.A., Bryant, G., Bates, G., Fojo, A., Regis, J., Jaffe, E.S., Steinberg, S.M., Goldspiel, B.R., Cheson, B.D. and Wittes, R.E. (1995) "Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas", Journal of Clinical Oncology 13, 381 - 386
  • Maloney, D.G., Grillo-Lopez, A.J., Bodkin, D.J., White, C.A., Lies, T.M., Royston, I., Varns, C., Rosenberg, J. and Levy, R. (1997) "IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non Hodgkin's lymphoma", Journal of Clinical Oncology 15, 3266 - 3274
  • Coiffier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., Johnson, P., Lister, A., Feuring-Buske, M., Radford, J.A., Capdeville, R., Diehl, V. and Reyes, F. (1998) "Rituxmab (Anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study", Blood 92, 1927 - 1932
  • Witzig, T.E., White, C.A., Wiseman, A., Gordon, L.I., Emmanouilides, C., Raubitschek, A., Janakiraman, N., Gutheil, J., Schilder, R.J., Spies, S., Silverman, D.H.S., Parker, E. and Grillo-Lopez, A.J. (1999) "Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed of refractory CD20+ B-cell non-Hodgkin's lymphoma", Journal of Clinical Oncology 17, 3793 - 3803
  • Vose, J.M., Wahl, R.L., Saleh, M., Rohatiner, A.Z., Knox, S.J., Radford, J.A., Zelenetz, A.D., Tidmarsh, G.F., Stagg, R.J. and Kaminski, M.S. (2000) "Multicenter Phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non Hodgkin's lymphomas", Journal of Clinical Oncology 18, 1315 - 1323
  • Jackson, Jr, D.V., Paschold, E.H., Spurr, C.L., Muss, H.B., Richards, III, F., Cooper, R.M., White, D.R., Stuart, J.J., Hopkins, J.O., Rich, Jr, R. and Wells, H.B. (1984) "Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion", Cancer 53, 2601 - 2606
  • Jackson, Jr, D.V., Sethi, V.S., Spurr, C.L., Willard, V., White, D.R., Richards, III, F., Stuart, J.J., Muss, H.B., Cooper, R.M., Homesley, H.D., Jobson, V.W. and Castle, M.C. (1981) "Intravenous vincristine infusion: phase I trial", Cancer 48, 2559 - 2564
  • Sarris, A.H., Romaguera, J.E., Hagemeister, F., Rodriguez, M.A., McLaughlin, P., Dang, N., Tsimberidou, A.M., Medeirors, L.J., Samuels, B., Oholendt, M., Burge, C. and Cabanillas, F. (1999) "Liposomal vincristine: a phase II trial in relapsed or refractory non-Hodgkin's lymphomas (NHL) (abstract)", Blood 94, 94a
  • Sarris, A.H., Hagemeister, F., Romaguera, J., Rodriguez, M.A., McLaughlin, P., Tsimberidou, A.M., Medeiros, L.J., Samuela, B., Pate, O., Oholendt, M., Kantarjian, H., Burge, C. and Cabanillas, F. (2000) "Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial", Annals of Oncology 11, 69 - 72
  • Sarris, A.H., Psyrri, A., Romaguera, J., Hagemeister, F., McLaughlin, P., Bachier, C., Mesina, O., Adams, L.M. and Cabanillas, F. (1998) "Phase I/II trial of infusional vinorelbine in relapsed or refractory lymphoma", Blood 92 (Suppl. 1), 621a
  • Bruno, S., Savvignano, R., Corrado, C., Aris Cancela, M.E., Milone, G., Lastriri, F.J. and De Tezanos Pinto, M. (1994) "Vinorelbine (NVB): a new vinca alkaloid active in refractory/relapsed lymphomas: a phase II study (abstract)", Proceedings of American Society of Clinical Oncology 13, 383
  • Balzarotti, M., Santoro, A., Tondini, C., Fornier, M. and Bonadonna, G. (1996) "Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma", Annals of Oncology 7, 970 - 972
  • Rule, S., Tighe, M., Davies, S. and Johnson, S. (1998) "Vinorelbine in the treatment of lymphoma", Haematological Oncology 16, 101 - 105
  • Case, Jr, D.C., Anderson, J., Ervin, T.J. and Gottlieb, A. (1991) "Phase II Trial of Ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: cancer and leukemia Group B study 8552", Haematological Oncology 9, 189 - 196
  • Tourani, J-M., Levy, V., Briere, J., Levy, R., Franks, C. and Andrieu, J-M. (1991) "Interleukin-2 therapy for refractory and relapsing lymphomas", European Journal of Cancer 27, 1676 - 1680
  • Fossa, A., Santoro, A., Hiddemann, W., treumper, L., Niederle, N., Buksmaui, S., Bonadonna, G., Seeber, S. and Nowrousian, M.R. (1991) "Gemcitabine as single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma", Journal of Clinical Oncology 17, 3789 - 3792
  • Wilson, W.H., Little, R., Pearson, D., Jaffe, E.S., Steinberg, S.M., Cheson, B.D., Humphrey, R., Kohler, D.R. and Elwood, P. (1998) "Phase II and dose-escalation with or without granulocyte colony-stimulating factory study of 9-aminocamptothecin in relapsed and refractory lymphomas", Journal of Clinical Oncology 16, 2345 - 2351
  • Ezzat, A., Khalifa, F., Berry, J., Khan, B., Raja, M.A. and Abdel-Warith, A. (1994) "E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma (abstract)", Proceedings of American Society of Clinical Oncology 13, 383
  • Riggs, C.E. (1996) "Antitumor antibiotics and related compounds", In: Perry, M.C., ed, The Chemotherapy Source Book (Williams and Wilkins, Baltimore), pp 345 - 385
  • Rowinsky, E.K. and Donehower, R.C. (1996) "Microtubule targeting drugs", In: Perry, M.C., ed, The Chemotherapy Source Book (Williams and Wilkins, Baltimore), pp 387 - 424
  • Aisner, J., Fram, R.J., Eisenberger, M. and Fontana, J.A. (1996) "Hormones and enzymes", In: Perry, M.C., ed, The Chemotherpy Source Book (Williams and Wilkins, Baltimore), pp 459 - 476
  • Multani, P.S., O'Days, S., Nadler, L.M. and Grossbard, M.L. (1998) "Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma", Clinical Cancer Research 4, 2599 - 2604
  • Kantarjian, H., Barlogie, B., Plunkett, W., Velasquez, W., McLaughlin, P., Riggs, S. and Cabanillas, F. (1983) "High-dose cytosine arabinoside in non-Hodgkin's lymphoma", Journal of Clinical Oncology 1, 689 - 694
  • Miller, T.P., Jones, S.E., Alberts, D.S. and Mackel, C. (1984) "Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas", Investigational New Drugs 2, 75 - 77
  • Tulpule, A., Schiller, G., Harvey-Buchanan, L.A., Lee, M., Espina, B.M., Khan, A.U., Boswell, W., Nathwani, B. and Levine, A.M. (1998) "Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma", Cancer 83, 2370 - 2376
  • Coonley, C.J., Warrell, Jr, R.P., Straus, D.J. and Young, C.W. (1983) "Clinical evaluation of 4-demethoxydaunorubicin in patients with advanced malignant lymphoma", Cancer Treatment Reviews 67, 949 - 950
  • Redman, J.R., Cabinallas, F., Velasquez, W.S., McLaughlin, P., Hagemeisre, F.B., Swan, Jr F., Rodriguez, M.A., Plunkett, W.K. and Keating, M.J. (1992) "Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma", Journal of Clinical Oncology 10, 790 - 794
  • Silver, R.T., Case, Jr, D.C., Wheeler, R.H., Miller, T.P., Stein, R.S., Stuart, J.J., Peterson, B.A., Rivkin, S.E. and Golomb, H.M. (1991) "Multicenter Clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease", Journal of Clinical Oncology 9, 754 - 761
  • Germann, N., Brienzam, S., Rotarski, M., Emile, J.F., Di Palma, M., Musset, M., Reynes, M., Soulie, P., Cvitkovic, E. and Misset, J.L. (1999) "Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients", Annals of Oncology 10, 351 - 354
  • Rotarski, M., Brienza, S., Gastiaburo, J., Musset, M., DiPalma, M., Lemooier, M.P., Farabos, C., Burki, F., Jasmin, C. and Misset, J.L. (1993) "Oxaliplatin (L-OHP): a new platinum analog: active in refractory/relapsed intermediate and low grade non-Hodgkin's lymphoma (NHL): a phase I-II study (abstract)", Proceedings of American Society of Clinical Oncology 12, 375
  • Goss, P., Stewart, A.K., Couture, F., Klasa, R., Gluck, S., Kaizer, L., Burkes, R., Charpentier, D., Palmer, M., Tye, L. and Dulude, H. (1999) "Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas", Leukemia and Lymphoma 34, 295 - 304
  • Preti, H.A., Plunkett, W., Sarris, A.H., Younes, A., Hagemeister, F., Rodriguez, M.A., Romaguera, J., McLaughlin, P., Bachier, C. and Cabanillas, F. (1995) "Preliminary results of a phase II trial of topotecan in patients with relapsing lymphoma", Blood 86 (Suppl. 11), 820a
  • Salminen, E., Nikkanen, V. and Lindholm, L. (1997) "Palliative chemotherapy in non-Hodgkin's lymphoma", Oncology 54, 108 - 111

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.